Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

New cystic fibrosis mouse models allow testing of therapies for W1282X nonsense mutations

Nov. 10, 2021

CG-223 demonstrates antifibrotic effects in a murine model of pulmonary fibrosis

Nov. 9, 2021

Virulent factors of P. aeruginosa isolates are upregulated under anaerobic conditions

Nov. 9, 2021

Analysis of lung phenotype in rat CF models using flexiVent and X-ray velocimetry

Nov. 8, 2021

New JAK inhibitors patented by Gossamer Bio

Nov. 8, 2021

Researchers develop a cystic fibrosis-related diabetes murine model

Nov. 8, 2021

F508del and G542X cystic fibrosis sheep models exhibit severe phenotype

Nov. 5, 2021

BPN-15477 corrects splicing defect caused by the c.2988G>A variant in CFTR

Nov. 5, 2021

ELD-607 reduces pulmonary inflammation and lung damage in vivo

Nov. 5, 2021

SP-101 administration restores airway epithelial function in cystic fibrosis

Nov. 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.